Evidence map›Paper›PMID 31380246›Full record

ReviewAdvanced pharmaceutical bulletin2019

Understanding Apoptosis and Apoptotic Pathways Targeted Cancer Therapeutics.

Rehmat Jan, Gul-E-Saba Chaudhry

Open access · diamondAbstract readReview
In one paragraph

Review in Advanced pharmaceutical bulletin, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 435 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
435citing papers in PubMed, 2 pooled it
27.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

435 citing papers in PubMed, 2 syntheses or guidelines pooled it, 857 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Mechanistic Insights intoInternational journal of molecular sciences · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Solvent-Guided Fractionation of GreenPlants (Basel, Switzerland) · 2026
    Article

375 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Rehmat JanInstitute of Marine Biotechnology, Universiti Terengganu Malaysia, 21030 Terengganu, Malaysia.ORCID https://orcid.org/0000-0001-9217-9084
Gul-E-Saba ChaudhryInstitute of Marine Biotechnology, Universiti Terengganu Malaysia, 21030 Terengganu, Malaysia.ORCID https://orcid.org/0000-0002-4555-8572
Universiti Malaysia Terengganu · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Various physiological processes involve appropriate tissue developmental process and homeostasis - the pathogenesis of several diseases connected with deregulatory apoptosis process. Apoptosis plays a crucial role in maintaining a balance between cell death and division, evasion of apoptosis results in the uncontrolled multiplication of cells leading to different diseases such as cancer. Currently, the development of apoptosis targeting anticancer drugs has gained much interest since cell death induced by apoptosis causes minimal inflammation. The understanding of complexities of apoptosis mechanism and how apoptosis is evolved by tumor cells to oppose cell death has focused research into the new strategies designed to induce apoptosis in cancer cells. This review focused on the underlying mechanism of apoptosis and the dysregulation of apoptosis modulators involved in the extrinsic and intrinsic apoptotic pathway, which include death receptors (DRs) proteins, cellular FLICE inhibitory proteins (c-FLIP), anti-apoptotic Bcl-2 proteins, inhibitors of apoptosis proteins (IAPs), tumor suppressor (p53) in cancer cells along with various current clinical approaches aimed to selectively induce apoptosis in cancer cells.

Indexed as

ApoptosisApoptosis pathwaysCancerCaspasesc-FLIPDeath receptorsTargeted drugs

Identifiers

PMID31380246
PMCPMC6664112
OpenAlexW2948680670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.